IHH Healthcare Berhad (KLSE:IHH)
Malaysia · Delayed Price · Currency is MYR | Market Cap | 67.60B +7.7% |
| Revenue (ttm) | 26.75B +7.3% |
| Net Income | 2.25B +1.0% |
| EPS | 0.25 +0.7% |
| Shares Out | 8.84B |
| PE Ratio | 30.12 |
| Forward PE | 27.08 |
| Dividend | 0.11 (1.30%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | 5,217,800 |
| Open | 7.89 |
| Previous Close | 7.89 |
| Day's Range | 7.54 - 7.89 |
| 52-Week Range | 7.10 - 10.48 |
| Beta | 0.14 |
| Analysts | Strong Buy |
| Price Target | 10.18 (+33.07%) |
| Earnings Date | Nov 27, 2026 |
About IHH Healthcare Berhad
IHH Healthcare Berhad, an investment holding company, provides healthcare services in Singapore, Malaysia, India, Greater China, Japan, Türkiye and Europe, and internationally. The company offers primary care services, such as outpatient treatment, check-ups, vaccinations, preventive care, and patient education services; secondary and tertiary care services, including medical emergencies and acute treatment, diagnostics and lab services; quaternary services comprising specialist consultative care, advanced treatment, complex surgery, and inpati... [Read more]
Full Company ProfileFinancial Performance
In 2025, IHH Healthcare Berhad's revenue was 25.75 billion, an increase of 5.59% compared to the previous year's 24.38 billion. Earnings were 2.10 billion, a decrease of -20.93%.
Financial StatementsAnalyst Summary
According to 23 analysts, the average rating for IHH stock is "Strong Buy." The 12-month stock price target is RM 10.18, which is an increase of 33.07% from the latest price.
News
Malaysia's IHH's unit loses Tokyo court case against Daiichi Sankyo over Fortis deal
Malaysia's IHH Healthcare said on Thursday that a Tokyo court has dismissed its unit's damage claims against Japan's Daiichi Sankyo tied to its 2018 acquisition of a stake in India's Fortis Healthcare...
Q2 2026 IHH Healthcare Bhd Earnings Presentation Transcript
Q2 2026 IHH Healthcare Bhd Earnings Presentation Transcript
Indian court directs forensic auditor appointment in Daiichi-Fortis case, IHH says
Malaysia's IHH Healthcare said on Tuesday that an Indian court directed the appointment of a forensic auditor in relation to certain applications filed by Japan's Daiichi Sankyo against Fortis Healthc...
IHH Healthcare Berhad Quarterly report: Q2 2026
IHH Healthcare Berhad has published its Q2 2026 quarterly earnings report on August 26, 2026.
IHH Healthcare Berhad Slides: Q2 2026
IHH Healthcare Berhad has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 26, 2026.
How IHH Healthcare CEO Prem Kumar Nair is planning for a longer-lived Asia
The head of Asia’s largest private health group is advancing clinical longevity, cancer care, AI and neighborhood-based treatment.
IHH Healthcare Collaborates with Infosys on a Multi-Country, AI-Powered ERP Transformation to Accelerate Growth
Powered by Infosys Topaz, the collaboration will help unify operations, optimize processes, and enable a future ready healthcare enterprise BENGALURU, India and KUALA LUMPUR, Malaysia and SINGAPORE, J...
Infosys collaborates with IHH Healthcare for AI-powered ERP transformation
Infosys, a global leader in AI-first business consulting and technology services, has announced a strategic collaboration with IHH Healthcare to drive a multi-year, enterprise-wide ERP transformation ...
IHH Healthcare Berhad Earnings Call Transcript: Q1 2026
Revenue and EBITDA grew 16% year-over-year on a constant currency basis, with strong results in Malaysia, India, and Turkey, while Singapore is expected to recover in H2 2026. Transformation initiatives and disciplined capital allocation support a double-digit ROE target by 2028. EBITDA margin guidance remains at 22%-24%.
IHH Healthcare Berhad Slides: Q1 2026
IHH Healthcare Berhad has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 25, 2026.
IHH Healthcare Berhad Quarterly report: Q1 2026
IHH Healthcare Berhad has published its Q1 2026 quarterly earnings report on May 25, 2026.
Why some CEOs are ditching 5-year plans while others are making 10-year bets
Christine Tan speaks with Roger Lee of TAL Apparel, Michael Mertin of AT&S and Dr Prem Kumar Nair of IHH Healthcare about how CEOs are navigating constant disruption, from tariffs and supply chain sho...
How global CEOs are navigating rising costs and supply chain disruption
Christine Tan speaks with Roger Lee of TAL Apparel, Dr Prem Kumar Nair of IHH Healthcare and Michael Mertin of AT&S about how rising energy costs, shipping volatility and supply chain bottlenecks are ...
IHH, DBS sign $194 million loan for safer antibiotic use
IHH Healthcare has signed a S$250 million ($196 million) sustainability-linked loan with Singapore's biggest bank DBS that ties part of the deal to better use of antibiotics at its four Singapore...
Fortis Healthcare surges nearly 3% as IHH commits to raise stake to 50% from 31%
Shares of Fortis Healthcare jumped sharply today, rising 2.13% to ₹825.35 on the NSE after Malaysia’s IHH Healthcare publicly committed to increasing its shareholding in the Indian hospital chain to…
IHH Healthcare Berhad Earnings Call Transcript: Q4 2025
Q4 2025 saw record revenue and EBITDA, with double-digit growth across key markets and strong margin performance. Malaysia and India led growth, while digital transformation and brownfield expansions drive future returns. Dividend payout increased, and outlook for 2026 remains positive.
IHH Healthcare Berhad Quarterly report: Q4 2025
IHH Healthcare Berhad has published its Q4 2025 quarterly earnings report on March 2, 2026.
IHH Healthcare Berhad Slides: Q4 2025
IHH Healthcare Berhad has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 2, 2026.
Fortis Healthcare shares gain today after IHH Healthcare outlines India expansion plan
Friday, February 20: Shares of Fortis Healthcare Limited traded higher after its largest shareholder, IHH Healthcare Berhad, detailed plans to...
IHH Healthcare Berhad Earnings Call Transcript: Q3 2025
Q3 2025 saw robust double-digit revenue and EBITDA growth on a constant currency basis, driven by higher patient volumes, day care expansion, and medical tourism, with margins maintained within guidance. Strategic milestones included the Fortis acquisition and Mount Elizabeth Orchard's reopening.
IHH Healthcare Berhad Quarterly report: Q3 2025
IHH Healthcare Berhad has published its Q3 2025 quarterly earnings report on November 27, 2025.
IHH Healthcare Berhad Slides: Q3 2025
IHH Healthcare Berhad has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 27, 2025.
IHH Healthcare Berhad Earnings Call Transcript: Q2 2025
Q2 2025 saw resilient financial results with 7% revenue and 2% EBITDA growth, and even stronger constant-currency gains, driven by increased admissions and a shift to daycare. Margins remained stable amid FX volatility and payer pressure, with robust segment performance and ongoing operational transformation.
IHH Healthcare Berhad Quarterly report: Q2 2025
IHH Healthcare Berhad has published its Q2 2025 quarterly earnings report on August 29, 2025.
IHH Healthcare Berhad Slides: Q2 2025
IHH Healthcare Berhad has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 29, 2025.